PT-141 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
PT-141 (Bremelanotide) is a Melanocortin receptor agonist researched for increased sexual desire in premenopausal women, improved sexual arousal, non-hormonal sexual enhancement. For beginners, start at the lower end of the dosage range (1.75 mg per dose (FDA-approved)) and administer on-demand, 45 minutes before anticipated activity; maximum 8 doses per month via subcutaneous self-injection.
What Is PT-141?
PT-141 (Bremelanotide) is a Melanocortin receptor agonist. Synthetic α-MSH analog targeting MC1R and MC4R for sexual desire modulation.
It is researched for its potential effects on increased sexual desire in premenopausal women, improved sexual arousal, non-hormonal sexual enhancement. One of the few FDA-approved peptide therapies and the only medication targeting sexual desire through melanocortin brain pathways rather than vascular mechanisms — treats desire itself, not just physical function.
For beginners: This guide assumes no prior peptide experience. We'll cover everything from what PT-141 is to how to reconstitute, inject, and structure your first cycle.
How Does PT-141 Work?
Activates melanocortin receptors MC1R and MC4R, with MC4R modulating sexual desire through hypothalamic neural circuits. Engages endogenous melanocortin pathways regulating arousal, desire, and sexual response — a completely different mechanism than PDE5 inhibitors like sildenafil.
Understanding the mechanism helps set realistic expectations about what PT-141 can and cannot do.
How Do You Get Started With PT-141?
Step 1 — Source: Purchase PT-141 from a vendor with third-party Certificate of Analysis (COA) testing. This confirms purity (aim for 98%+) and rules out contamination.
Step 2 — Supplies: You'll need bacteriostatic water, insulin syringes (1mL/100-unit), alcohol swabs, and a clean workspace.
Step 3 — Reconstitute: Add BAC water to the PT-141 vial — use our peptide calculator for exact amounts. Let the water run down the side of the vial; never spray directly on the powder. Swirl gently.
Step 4 — Dose: Draw 1.75 mg per dose (FDA-approved) using the calculator's syringe unit conversion.
Step 5 — Inject: Clean the injection site with alcohol. Pinch a fold of abdominal fat and insert the needle at 45° for subcutaneous injection. Push the plunger slowly and hold for 5 seconds.
Calculate Your PT-141 Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for PT-141.
Open Calculator →What Should Your First PT-141 Cycle Look Like?
Dosage: Start at the lower end of 1.75 mg per dose (FDA-approved). This lets you assess tolerance before committing to a full cycle.
Frequency: on-demand, 45 minutes before anticipated activity; maximum 8 doses per month via subcutaneous self-injection.
Duration: on-demand acute dosing; no continuous cycle required. Don't cut cycles short — many Melanocortin receptor agonist effects take weeks to fully manifest.
Off-cycle: Plan a 4-week break before starting another cycle.
What Side Effects Should Beginners Watch For?
Nausea (40% incidence, especially first injection), flushing (20%), injection site reactions (13%), headache (11%). Transient blood pressure increases (2-3 mmHg average). Contraindicated in uncontrolled hypertension.
As a beginner, track everything — dose, time, injection site, and any effects (positive or negative). This data helps optimize future cycles.
What Are Common Beginner Mistakes?
Not using BAC water: Sterile water lacks the preservative that prevents bacterial growth. Always use bacteriostatic water.
Inconsistent dosing: Skipping doses or varying timing significantly reduces outcomes. Set a daily alarm.
Poor storage: Reconstituted PT-141 must stay refrigerated at 2-8°C. Leaving it at room temperature degrades the compound rapidly.
Buying cheap: Low-cost peptides without COA testing may be underdosed, contaminated, or mislabeled. Quality matters more than price.
Bottom Line for PT-141 Beginners
Start at the lower end of 1.75 mg per dose (FDA-approved), dose on-demand, 45 minutes before anticipated activity; maximum 8 doses per month, cycle for on-demand acute dosing; no continuous cycle required, and track everything. Source from COA-tested vendors and follow proper reconstitution protocol.
Read our complete peptide beginner's guide for general peptide education beyond PT-141.
Complete Guide
PT-141 (Bremelanotide): Research
Related Reading
- PT-141 Dosage Guide
- PT-141 Benefits
- PT-141 Side Effects
- PT-141 Stacking Guide
- PT-141 Cycle Guide
- PT-141 Research
Research-Grade Sourcing
If you're going to research PT-141, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is PT-141?
PT-141 (Bremelanotide) is a Melanocortin receptor agonist. Synthetic α-MSH analog targeting MC1R and MC4R for sexual desire modulation. It is researched for increased sexual desire in premenopausal women, improved sexual arousal, non-hormonal sexual enhancement.
What is the recommended PT-141 dosage?
Common dosages: 1.75 mg per dose (FDA-approved) administered on-demand, 45 minutes before anticipated activity; maximum 8 doses per month via subcutaneous self-injection. Cycle length: on-demand acute dosing; no continuous cycle required. Half-life: peak effects 15-30 minutes post-injection. Use our peptide calculator for exact reconstitution math.
What are the side effects of PT-141?
Nausea (40% incidence, especially first injection), flushing (20%), injection site reactions (13%), headache (11%). Transient blood pressure increases (2-3 mmHg average). Contraindicated in uncontrolled hypertension.
Is PT-141 safe?
PT-141 has shown a preliminary safety profile in research. FDA-approved (2019) as Vyleesi for hypoactive sexual desire disorder in premenopausal women. Prescription medication. Off-label use for males by some providers. All research should follow appropriate safety protocols.